[1]Mundra V, Gerling IC, Mahato RI. Mesenchymal stem cell-based therapy. Mol Pharm. 2013;10(1):77-89.
[2]Balaji S, Keswani SG, Crombleholme TM. The Role of Mesenchymal Stem Cells in the Regenerative Wound Healing Phenotype. Adv Wound Care (New Rochelle). 2012;1(4): 159-165.
[3]von Bahr L, Batsis I, Moll G, et al. Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells. 2012;30(7):1575-1578.
[4]Kim HO, Choi SM, Kim HS. Mesenchymal stem cell derived secretome and macrovesicles as a cell free therapeutics for neurodegenerative disorders. Tissue Eng Regen Med. 2013; 10(3):93-101.
[5]Katagiri W, Osugi M, Kawai T, et al. First-in-human study and clinical case reports of the alveolar bone regeneration with the secretome from human mesenchymal stem cells. Head Face Med. 2016;12:5.
[6]Ulivi V, Tasso R, Cancedda R, et al. Mesenchymal stem cell paracrine activity is modulated by platelet lysate: induction of an inflammatory response and secretion of factors maintaining macrophages in a proinflammatory phenotype. Stem Cells Dev. 2014;23(16):1858-1869.
[7]Engel FB . Stem Cell Secretome and Paracrine Activity[M]// Stem Cells and Cardiac Regeneration[A]. Springer International Publishing, 2016.
[8]Pawitan JA. Prospect of stem cell conditioned medium in regenerative medicine. Biomed Res Int. 2014;2014:965849.
[9]Inukai T, Katagiri W, Yoshimi R, et al. Novel application of stem cell-derived factors for periodontal regeneration. Biochem Biophys Res Commun. 2013;430(2):763-768.
[10]Kim J, Lee JH, Yeo SM, et al. Stem cell recruitment factors secreted from cord blood-derived stem cells that are not secreted from mature endothelial cells enhance wound healing. In Vitro Cell Dev Biol Anim. 2014;50(2):146-154.
[11]Song SW, Kim KE, Choi JW, et al. Proteomic Analysis and Identification of Paracrine Factors in Mesenchymal Stem Cell-Conditioned Media under Hypoxia. Cell Physiol Biochem. 2016;40(1-2):400-410.
[12]Overath JM, Gauer S, Obermüller N, et al. Short-term preconditioning enhances the therapeutic potential of adipose- derived stromal/stem cell-conditioned medium in cisplatin-induced acute kidney injury. Exp Cell Res. 2016; 342(2):175-183.
[13]Jiang RH, Wu CJ, Xu XQ, et al. Hypoxic conditioned medium derived from bone marrow mesenchymal stromal cells protects against ischemic stroke in rats. J Cell Physiol. 2019;234(2): 1354-1368.
[14]Wu Y, Wang J, Scott PG, et al. Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen. 2007; 15 Suppl 1:S18-26.
[15]Li M, Zhao Y, Hao H, et al. Mesenchymal stem cell- conditioned medium improves the proliferation and migration of keratinocytes in a diabetes-like microenvironment. Int J Low Extrem Wounds. 2015;14(1): 73-86.
[16]Chen J, Li Y, Hao H, et al. Mesenchymal Stem Cell Conditioned Medium Promotes Proliferation and Migration of Alveolar Epithelial Cells under Septic Conditions In Vitro via the JNK-P38 Signaling Pathway. Cell Physiol Biochem. 2015; 37(5):1830-1846.
[17]Chen Q, Liang Q, Zhuang W, et al. Tenocyte proliferation and migration promoted by rat bone marrow mesenchymal stem cell- derived conditioned medium. Biotechnol Lett. 2018; 40(1): 215-224.
[18]Ando Y, Matsubara K, Ishikawa J, et al. Stem cell-conditioned medium accelerates distraction osteogenesis through multiple regenerative mechanisms. Bone. 2014;61:82-90.
[19]Nagata M, Iwasaki K, Akazawa K, et al. Conditioned Medium from Periodontal Ligament Stem Cells Enhances Periodontal Regeneration. Tissue Eng Part A. 2017;23(9-10):367-377.
[20]白海,吴冰,王存邦,等.人骨髓间充质干细胞及条件培养液对异体T淋巴细胞分泌功能的影响[J].中国组织工程研究, 2012,16(23): 4204-4208.
[21]刘新宾,张红超,郭子宽.骨髓间充质干细胞条件培养液对H2O2损伤大鼠心肌细胞的保护[J].中国组织工程研究,2012,16(1): 22-26.
[22]Qi L, Wang R, Shi Q, et al. Umbilical cord mesenchymal stem cell conditioned medium restored the expression of collagen II and aggrecan in nucleus pulposus mesenchymal stem cells exposed to high glucose. J Bone Miner Metab. 2018 Sep 5. doi: 10.1007/s00774-018-0953-9. [Epub ahead of print]
[23]Hu G, Xu JJ, Deng ZH, et al. Supernatant of bone marrow mesenchymal stromal cells induces peripheral blood mononuclear cells possessing mesenchymal features. Int J Biol Sci. 2011;7(3):364-375.
[24]Jiang CM, Liu J, Zhao JY, et al. Effects of hypoxia on the immunomodulatory properties of human gingiva-derived mesenchymal stem cells. J Dent Res. 2015;94(1):69-77.
[25]Lee TJ, Jang J, Kang S, et al. Mesenchymal stem cell-conditioned medium enhances osteogenic and chondrogenic differentiation of human embryonic stem cells and human induced pluripotent stem cells by mesodermal lineage induction. Tissue Eng Part A. 2014;20(7-8): 1306-1313.
[26]Cortes-Dericks L, Froment L, Kocher G, et al. Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines. Stem Cell Res Ther. 2016;7:25.
[27]Hendudari F, Piryaei A, Hassani SN, et al. Combined effects of low-level laser therapy and human bone marrow mesenchymal stem cell conditioned medium on viability of human dermal fibroblasts cultured in a high-glucose medium. Lasers Med Sci. 2016;31(4):749-757.
[28]He J, Cai Y, Luo LM, et al. Hypoxic adipose mesenchymal stem cells derived conditioned medium protects myocardial infarct in rat. Eur Rev Med Pharmacol Sci. 2015;19(22): 4397-4406.
[29]Faezi M, Nasseri Maleki S, Aboutaleb N, et al. The membrane mesenchymal stem cell derived conditioned medium exerts neuroprotection against focal cerebral ischemia by targeting apoptosis. J Chem Neuroanat. 2018;94:21-31.
[30]Szekiova E, Slovinska L, Blasko J, et al. The neuroprotective effect of rat adipose tissue-derived mesenchymal stem cell-conditioned medium on cortical neurons using an in vitro model of SCI inflammation. Neurol Res. 2018;40(4):258-267.
[31]Liu B, Ding F, Hu D, et al. Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to- mesenchymal transition via the TLR4/NF-κB signaling pathway in vivo and in vitro. Stem Cell Res Ther. 2018;9(1):7.
[32]Pouya S, Heidari M, Baghaei K, et al. Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis. Int Immunopharmacol. 2018;54:86-94.
[33]Kay AG, Long G, Tyler G, et al. Mesenchymal Stem Cell- Conditioned Medium Reduces Disease Severity and Immune Responses in Inflammatory Arthritis. Sci Rep. 2017;7(1):18019.
[34]Zhou BR, Xu Y, Guo SL, et al. The effect of conditioned media of adipose-derived stem cells on wound healing after ablative fractional carbon dioxide laser resurfacing. Biomed Res Int. 2013;2013:519126.
[35]Prakoeswa CRS, Natallya FR, Harnindya D, et al. The efficacy of topical human amniotic membrane-mesenchymal stem cell-conditioned medium (hAMMSC-CM) and a mixture of topical hAMMSC-CM + vitamin C and hAMMSC-CM + vitamin E on chronic plantar ulcers in leprosy:a randomized control trial. J Dermatolog Treat. 2018;29(8):835-840.
[36]Fukuoka H, Suga H. Hair Regeneration Treatment Using Adipose-Derived Stem Cell Conditioned Medium: Follow-up With Trichograms. Eplasty. 2015;15:e10.
[37]Xiang J, Hu J, Shen T, et al. Bone marrow mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke in type 2 diabetic rats. Neurosci Lett. 2017;644: 62-66.
[38]Dreixler JC, Poston JN, Balyasnikova I, et al. Delayed administration of bone marrow mesenchymal stem cell conditioned medium significantly improves outcome after retinal ischemia in rats. Invest Ophthalmol Vis Sci. 2014;55(6): 3785-3796.
[39]Cheng Z, Bosco DB, Sun L, et al. Neural Stem Cell-Conditioned Medium Suppresses Inflammation and Promotes Spinal Cord Injury Recovery. Cell Transplant. 2017;26(3):469-482.
[40]Suto N, Mieda T, Iizuka A, et al. Morphological and Functional Attenuation of Degeneration of Peripheral Neurons by Mesenchymal Stem Cell-Conditioned Medium in Spinocerebellar Ataxia Type 1-Knock-in Mice. CNS Neurosci Ther. 2016;22(8):670-676.
[41]Li M, Luan F, Zhao Y, et al. Mesenchymal stem cell-conditioned medium accelerates wound healing with fewer scars. Int Wound J. 2017;14(1):64-73.
[42]Sato C, Yamamoto Y, Funayama E, et al. Conditioned Medium Obtained from Amnion-Derived Mesenchymal Stem Cell Culture Prevents Activation of Keloid Fibroblasts. Plast Reconstr Surg. 2018;141(2):390-398.
[43]Iso Y, Usui S, Toyoda M, et al. Bone marrow-derived mesenchymal stem cells inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia after arterial injury in rats. Biochem Biophys Rep. 2018;16:79-87.
[44]Inukai T, Katagiri W, Yoshimi R, et al. Novel application of stem cell-derived factors for periodontal regeneration. Biochem Biophys Res Commun. 2013;430(2):763-768.
[45]Kawai T, Katagiri W, Osugi M, et al. Secretomes from bone marrow-derived mesenchymal stromal cells enhance periodontal tissue regeneration. Cytotherapy. 2015;17(4): 369-381.
[46]Li P, Zhou H, Di G, et al. Mesenchymal stem cell-conditioned medium promotes MDA-MB-231 cell migration and inhibits A549 cell migration by regulating insulin receptor and human epidermal growth factor receptor 3 phosphorylation. Oncol Lett. 2017;13(3):1581-1586. |